Epigenetic aging acceleration, social adversity and type 2 diabetes in postmenopausal women
In over 1,500 postmenopausal non-diabetic women from the Women's Health Initiative, greater epigenetic aging acceleration was seen in type 2 diabetes (univariate significance only) and insulin resistance and in African American compared with white women; social determinants and aging acceleration jointly mediated racial differences in glucometabolic outcomes only to a limited extent. [1]
Automatic summary · not editorially reviewed
The key findings
Greater epigenetic aging acceleration was observed in type 2 diabetes, but with only univariate significance, and in insulin resistance and in African American rather than white women. [1]
Social determinants of health were associated with greater aging acceleration, but their combined impact on the greater accelerated aging in African American women was minimal. [1]
The authors describe the mediation findings as exploratory and hypothesis-generating and call for validation studies. [1]
The source at a glance
- Study type / format
- Abstract of a cohort study with cross-sectional baseline analysis and mediation analysis
- Population / context
- More than 1,500 postmenopausal non-diabetic women from the Women's Health Initiative
- Summary based on
- Study abstract
- Original publication
- August 3, 2026
Aging acceleration and glucometabolic outcomes in WHI women
The study asked whether accelerated biological aging relates to type 2 diabetes and to insulin resistance measured at baseline in non-diabetic women, and how social adversity fits in. Data came from the Women's Health Initiative: more than 1,500 postmenopausal non-diabetic women, with clinical and social determinants of health variables and genome-wide DNA methylation data. Aging acceleration was calculated with Levine's clock. Diabetic outcome was followed for a mean of 19 years, while baseline insulin resistance was measured cross-sectionally using fasting serum samples. Greater aging acceleration was observed in type 2 diabetes, but with only univariate significance, and in insulin resistance, and in African American rather than white women.
Supporting source [1]
Social determinants and mediation of racial differences
Social determinants of health were associated with greater aging acceleration, but their impact on the greater accelerated aging in African American women varied, and in combination it was minimal. Although aging acceleration had greater influence than social determinants on the racial difference in glucometabolic outcomes, these parameters jointly mediated the type 2 diabetes and insulin resistance pathways by race only to a limited extent. The authors describe these mediation findings as exploratory and hypothesis-generating.
Supporting source [1]
Exploratory mediation findings need validation
The authors state that their mediation findings warrant validation studies to better understand socio-glucometabolic pathways shared with epigenetic aging processes and to inform early risk stratification among at-risk older women for disease prevention and reduced racial health inequity. This abstract reports associations, not causes; the diabetes finding reached only univariate significance. The full text was not reviewed.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. The diabetes finding reached only univariate significance, and the authors call the mediation results exploratory and hypothesis-generating, requiring validation. Associations are not causes.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Jung SY. · europepmc.org · August 3, 2026